Akari Therapeutics (AKTX)
NASDAQ:AKTX
Holding AKTX?
Track your performance easily

Akari Therapeutics (AKTX) Technical Analysis

274 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
2Neutral
10Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Akari Therapeutics’s (AKTX) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting Akari Therapeutics is a Buy.
Akari Therapeutics’s (AKTX) 20-Day exponential moving average is 3.43, while Akari Therapeutics’s (AKTX) share price is $3.16, making it a Sell.
Akari Therapeutics’s (AKTX) 50-Day exponential moving average is 3.38, while Akari Therapeutics’s (AKTX) share price is $3.16, making it a Sell.

Akari Therapeutics (AKTX) Pivot Points

Sep 20, 2024, 12:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.89
3.05
3.18
3.34
3.47
3.63
3.76
Fibonacci
3.05
3.16
3.23
3.34
3.45
3.52
3.63
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akari Therapeutics (AKTX) Moving Averages

Sep 20, 2024, 12:37 AM
Period
Simple
Exponential
MA5
3.26Sell
3.26Sell
MA10
3.31Sell
3.34Sell
MA20
3.53Sell
3.43Sell
MA50
3.61Sell
3.38Sell
MA100
2.90Buy
3.11Buy
MA200
2.61Buy
2.97Buy
Akari Therapeutics’s (AKTX) 10-Day exponential moving average is 3.34, while Akari Therapeutics’s (AKTX) share price is $3.16, making it a Sell.
Akari Therapeutics’s (AKTX) 100-Day exponential moving average is 3.11, while Akari Therapeutics’s (AKTX) share price is $3.16, making it a Buy.
Akari Therapeutics’s (AKTX) stock price is $3.16 and Akari Therapeutics’s (AKTX) 50-day simple moving average is 3.61, creating a Sell signal.
Akari Therapeutics’s (AKTX) stock price is $3.16 and Akari Therapeutics’s (AKTX) 100-day simple moving average is 2.90, creating a Buy signal.
Akari Therapeutics’s (AKTX) stock price is $3.16 and Akari Therapeutics’s (AKTX) 200-day simple moving average is 2.61, creating a Buy signal.

Akari Therapeutics (AKTX) Technical Indicators

Sep 20, 2024, 12:37 AM
Name
Value
Implied Action
RSI (14)
39.38
Neutral
STOCH (9,6)
14.01
Buy
STOCHRSI (14)
11.37
Buy
MACD (12,26)
-0.09
Buy
ADX (14)
12.11
Buy
Williams %R
-100.00
Buy
CCI (14)
-113.45
Buy
ATR (14)
0.34
-
Ultimate Oscillator
35.38
Neutral
ROC
-17.37
Sell
Akari Therapeutics’s (AKTX) Relative Strength Index (RSI) is 39.38, creating a Neutral signal.
Akari Therapeutics’s (AKTX) Trend Strength Indicator (ADX) is 12.11, creating a Buy signal.
Akari Therapeutics’s (AKTX) Commodity Channel Index (CCI) is -113.45, creating a Buy signal.
Akari Therapeutics’s (AKTX) Price Rate of Change (ROC) is -17.37, creating a Sell signal.

FAQ

Is AKTX a Buy, Hold, or Sell?
Based on AKTX’s technical indicators, AKTX is a Hold.
    What is AKTX’s RSI (14)?
    AKTX’s RSI (14) is 39.38, which suggests AKTX is a Neutral.
      What is AKTX’s MACD?
      AKTX’s MACD is -0.09, which suggests AKTX is a Buy.
        What is AKTX’s 5-day moving average?
        AKTX’s 5-day moving average is 3.26, which suggests AKTX is a Sell.
          What is AKTX’s 20-day moving average?
          AKTX 20-day moving average is 3.53, which suggests AKTX is a Sell.
            What is AKTX’s 50-day moving average?
            AKTX’s 50-day moving average is 3.61, which suggests AKTX is a Sell.
              What is AKTX’s 200-day moving average?
              AKTX’s 200-day moving average is 2.61, which suggests AKTX is a Buy.
                What is AKTX’s Williams % R (14)?
                AKTX’s Williams % R (14) is -100.00, which suggests AKTX is a Buy.
                  What is AKTX’s CCI (14)?
                  AKTX’s CCI (14) is -113.45, which suggests AKTX is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis